PM: decision on the application for modification of an agreed PIP
Decision date
Compliance check done
No
Decision
P/0339/2024 : EMA decision of 13 September 2024 on the acceptance of a modification of an agreed paediatric investigation plan for daratumumab (Darzalex), (EMEA-002152-PIP01-17-M04)